Data / Form D filings / Zacharon Pharmaceuticals Inc.
Zacharon Pharmaceuticals Inc.: Form D filings
Zacharon Pharmaceuticals Inc., a pharmaceuticals company in San Diego, CA, filed 3 Form D notices with the SEC between 2010 and 2012. The latest, on April 4, 2012, reports $33,000 sold of a $48,001 offering to 1 investor.
Find out what Zacharon Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5626 OBERLIN DRIVE, SUITE 100, San Diego, CA, 92121
- Phone
- (858) 754-3030
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1448633
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 4, 2012 | New notice | $48,001 | $33,000 | $15,001 | 1 | Mar 22, 2012 | sec.gov |
| Mar 24, 2011 | New notice | $15,001 | $15,001 | $0 | 1 | Mar 11, 2011 | sec.gov |
| Jun 24, 2010 | New notice | $1,876,000 | $500,000 | $1,376,000 | 1 | May 14, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas J. Downs | Executive Officer | |
| Court B. Turner | Executive Officer, Director | |
| Robin M. Jackman | Executive Officer, Director | |
| Jay B. Lichter | Director | |
| Timothy B. Scott | Director | |
| Charles A. Glass | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 2, 2012 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Zacharon Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.